Precision Biosciences Inc (DTIL)

07:56 AM

Precision BioSciences (DTIL) Poised for Growth with ARCUS Technology and Strategic Partnerships - HPBL

07:56 AM

Jan 19, 2025

Allogene Therapeutics vs. Precision BioSciences: A Deep Dive into Two Promising Gene Therapy Stocks – Market - HPBL

Jan 19, 2025

Jan 12, 2025

Geode Capital Management LLC Raises Holdings in Precision BioSciences, Inc. (NASDAQ:DTIL) - Defense World

Jan 12, 2025

Jan 12, 2025

Precision BioSciences (NASDAQ:DTIL) Earns “Buy” Rating from HC Wainwright - Defense World

Jan 12, 2025

Jan 12, 2025

Precision BioSciences (NASDAQ:DTIL) Raised to “Outperform” at BMO Capital Markets - Defense World

Jan 12, 2025

Jan 10, 2025

BMO Capital Upgrades Precision BioSciences (DTIL) - MSN

Jan 10, 2025

Jan 10, 2025

Precision BioSciences' Gene Editing Platform Has Differentiated Mechanism, And Is Potentially Competitive: Analyst - Benzinga

Jan 10, 2025

Jan 10, 2025

Precision BioSciences Shares Surge 60% After Breakthrough Clinical Results for OTC Deficiency Treatment - HPBL

Jan 10, 2025

Jan 10, 2025

Precision Bio stock upgraded at BMO (update) (DTIL:NASDAQ) - Seeking Alpha

Jan 10, 2025

Jan 10, 2025

Precision BioSciences upgraded to Outperform at BMO on favorable risk/reward - Investing.com Canada

Jan 10, 2025

Jan 10, 2025

Pre-Market Surge For Precision BioSciences (DTIL) On Groundbreaking Trial Data - Stocks Telegraph

Jan 10, 2025

Jan 10, 2025

Precision BioSciences shares soar on promising gene editing trial results By Investing.com - Investing.com Australia

Jan 10, 2025

Jan 10, 2025

Precision BioSciences shares soar on promising gene editing trial results - Investing.com

Jan 10, 2025

Jan 10, 2025

Head-To-Head Review: Allogene Therapeutics (NASDAQ:ALLO) versus Precision BioSciences (NASDAQ:DTIL) - Defense World

Jan 10, 2025

Jan 09, 2025

Precision BioSciences Announces Complete Clinical Response in First Infant Dosed by Partner iECURE in Ongoing Phase 1/2 Clinical Trial in Ornithine Transcarbamylase (OTC) Deficiency - BioSpace

Jan 09, 2025

Jan 09, 2025

DTILPrecision BioSciences, Inc. Latest Stock News & Market Updates - StockTitan

Jan 09, 2025

Jan 09, 2025

Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) invests $10M in Alamar Biosciences, Inc. to Advance Precision Medicine in Alzheimer’s Disease - The Scientist

Jan 09, 2025

Jan 09, 2025

Precision BioSciences Gene Therapy Shows Breakthrough Success in Infant OTC Deficiency Trial - StockTitan

Jan 09, 2025

Jan 08, 2025

Precision BioSciences projects extended cash runway into 2026 - Investing.com

Jan 08, 2025

Jan 08, 2025

Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator (DxA) invests $10M in Alamar Biosciences, Inc. to Advance Precision Medicine in Alzheimer's Disease - PR Newswire

Jan 08, 2025

Jan 02, 2025

Precision Biosciences director Germano purchases $16,186 in stock By Investing.com - Investing.com Canada

Jan 02, 2025

Jan 02, 2025

Insider Buying: Geno Germano Acquires Shares in Precision BioSci - GuruFocus.com

Jan 02, 2025

Jan 02, 2025

Precision Biosciences director Germano purchases $16,186 in stock - Investing.com

Jan 02, 2025

Jan 01, 2025

Precision BioSciences stock hits 52-week low at $4.12 By Investing.com - Investing.com Canada

Jan 01, 2025

Dec 31, 2024

Precision Biosciences director Kevin Buehler buys $21,081 in stock By Investing.com - Investing.com Nigeria

Dec 31, 2024

Dec 31, 2024

Precision BioSciences stock hits 52-week low at $4.12 - Investing.com India

Dec 31, 2024

Dec 31, 2024

Precision Biosciences CFO buys $10,036 in common stock By Investing.com - Investing.com Canada

Dec 31, 2024